Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA; Irkutsk State Medical University, Irkutsk, Russia.
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
World Neurosurg. 2018 Jul;115:e337-e348. doi: 10.1016/j.wneu.2018.04.048. Epub 2018 Apr 17.
Glioma resection with fluorescein sodium (FNa) guidance has a potential drawback of nonspecific leakage of FNa from nontumor areas with a compromised blood-brain barrier. We investigated the diagnostic accuracy of in vivo confocal laser endomicroscopy (CLE) after FNa administration to differentiate normal brain, injured normal brain, and tumor tissue in an animal glioma model.
GL261-Luc2 gliomas in C57BL/6 mice were used as a brain tumor model. CLE images of normal, injured normal, and tumor brain tissues were collected after intravenous FNa administration. Correlative sections stained with hematoxylin and eosin were taken at the same sites. A set of 40 CLE images was given to 1 neuropathologist and 3 neurosurgeons to assess diagnostic accuracy and rate image quality (1-10 scale). Additionally, we developed a deep convolution neural network (DCNN) model for automatic image classification.
The mean observer accuracy for correct diagnosis of glioma compared with either injured or uninjured brain using CLE images was 85%, and the DCNN model accuracy was 80%. For differentiation of tumor from nontumor tissue, the experts' mean accuracy, specificity, and sensitivity were 90%, 86%, and 96%, respectively, with high interobserver agreement overall (Cohen κ = 0.74). The percentage of correctly identified images was significantly higher for images with a quality rating >5 (104/116, 90%) than for images with a quality rating ≤5 (32/44, 73%) (P = 0.007).
With sufficient FNa present in tissues, CLE was an effective tool for intraoperative differentiation among normal, injured normal, and tumor brain tissue. Clinical studies are warranted to confirm these findings.
荧光素钠(FNa)引导下的脑胶质瘤切除术存在一个潜在的缺点,即血脑屏障受损的非肿瘤区域会出现 FNa 的非特异性渗漏。我们研究了 FNa 给药后,在动物脑胶质瘤模型中,体内共聚焦激光内镜(CLE)对正常脑、损伤正常脑和肿瘤组织的诊断准确性。
GL261-Luc2 脑胶质瘤在 C57BL/6 小鼠中被用作脑肿瘤模型。静脉注射 FNa 后,采集正常、损伤正常和肿瘤脑组织的 CLE 图像。在同一部位采集苏木精和伊红染色的相关切片。一组 40 张 CLE 图像由 1 名神经病理学家和 3 名神经外科医生进行评估,以评估诊断准确性和图像质量评分(1-10 分)。此外,我们还开发了一个深度卷积神经网络(DCNN)模型进行自动图像分类。
使用 CLE 图像正确诊断脑胶质瘤与损伤或未损伤脑的观察者平均准确率为 85%,DCNN 模型的准确率为 80%。对于肿瘤与非肿瘤组织的区分,专家的平均准确率、特异性和敏感性分别为 90%、86%和 96%,总体观察者间一致性较高(Cohen κ=0.74)。质量评分>5 的图像中,正确识别的图像百分比(104/116,90%)显著高于质量评分≤5 的图像(32/44,73%)(P=0.007)。
在组织中存在足够的 FNa 时,CLE 是一种有效的术中鉴别正常、损伤正常和肿瘤脑组织的工具。需要开展临床研究来验证这些发现。